7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with pergolide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonaventure, P; Janssen, PF; Leysen, JE; Schotte, A | 1 |
Fici, GJ; Sethy, VH; VonVoigtlander, PF; Wu, H | 1 |
2 other study(ies) available for 7-hydroxy-2-n,n-dipropylaminotetralin and pergolide
Article | Year |
---|---|
Endogenous dopamine limits the binding of antipsychotic drugs to D3 receptors in the rat brain: a quantitative autoradiographic study.
Topics: Animals; Antipsychotic Agents; Autoradiography; Brain; Domperidone; Dopamine; Humans; Male; Pergolide; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes | 1996 |
D1 dopamine receptor activity of anti-parkinsonian drugs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Apomorphine; Benzazepines; Benzothiazoles; Bromocriptine; Cells, Cultured; Cerebellum; Clozapine; Cyclic AMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiazoles | 1997 |